{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Kokas Z"],"funding":["University of Szeged","University of Szeged Open Access Fund",": University of Szeged"],"pagination":["e0264328"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8893632"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["17(3)"],"pubmed_abstract":["A patients
Because of the past 3 decades' extensive research, several disease modifying therapies became available, thus a paradigm change is multiple sclerosis care was necessary. In 2018 a therapeutic guideline was created recommending that treatment of persons with multiple sclerosis should take place in specified care units where the entire spectrum of disease modifying therapies is available, patient monitoring is ensured, and therapy side effects are detected and treated promptly. In 2019 multiple sclerosis care unit criteria were developed, emphasizing personnel and instrumental requirements to provide most professional care. However, no survey was conducted assessing the real-world adaptation of these criteria.Objective
To assess whether Hungarian care units fulfil "],"journal":["PloS one"],"pubmed_title":["Do Hungarian multiple sclerosis care units fulfil international criteria?"],"pmcid":["PMC8893632"],"funding_grant_id":["TUDFO/47138-1/2019-ITM","GINOP 2.3.2-15-2016-00034","EFOP 3.6.3-VEKOP-16-2017-00009","5535"],"pubmed_authors":["Sandi D","Kapas I","Jobbagy Z","Molnar G","Koves A","Dobos E","Csepany T","Satori M","Szolnoki Z","Pentek S","Dioszeghy P","Kerenyi L","Fazekas F","Matyas K","Varga A","Jakab G","Fricska-Nagy Z","Bense E","Birkas AJ","Imre P","Vecsei L","Milanovich D","Kovacs K","Deme I","Klivenyi P","Rum G","Bors L","Nagy ZA","Kincses ZT","Fuvesi J","Kriston D","Bencsik K","Gerocs Z","Biernacki T","Kokas Z","Katona G","Kristof P"],"additional_accession":[]},"is_claimable":false,"name":"Do Hungarian multiple sclerosis care units fulfil international criteria?","description":"A patients
Because of the past 3 decades' extensive research, several disease modifying therapies became available, thus a paradigm change is multiple sclerosis care was necessary. In 2018 a therapeutic guideline was created recommending that treatment of persons with multiple sclerosis should take place in specified care units where the entire spectrum of disease modifying therapies is available, patient monitoring is ensured, and therapy side effects are detected and treated promptly. In 2019 multiple sclerosis care unit criteria were developed, emphasizing personnel and instrumental requirements to provide most professional care. However, no survey was conducted assessing the real-world adaptation of these criteria.Objective
To assess whether Hungarian care units fulfil ","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-19T21:42:15.594Z","creation":"2025-04-19T21:42:15.594Z"},"accession":"S-EPMC8893632","cross_references":{"pubmed":["35239686"],"doi":["10.1371/journal.pone.0264328"]}}